Skip to search formSkip to main contentSkip to account menu

ON 01910

Known as: ON-01910, ON01910 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

GlycineSulfones

Narrower (2)

ON 01910.Narigosertib
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Abstract 3493: ON 01910. Na, a clinical trial stage multi-kinase inhibitor, induces apoptosis in chronic lymphocytic leukemia (CLL) cells through inhibition of PI3K/AKT and activation of the JNK…
Chronic Lymphocytic leukemia (CLL), the most common leukemia in Western countries, is a clinically heterogeneous disease… 
2008
2008
ON01910. Na enhances chemotherapeutic agents active in drug resistant tumors
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)